On last week’s Q3 earnings call, Addus HomeCare Corporation (Nasdaq: ADUS) effectively declared that its “short pause” on M&A activity was officially...
Addus HomeCare Corporation (Nasdaq: ADUS) announced Wednesday it has reached a definitive agreement to acquire an Ohio hospice provider for $192 million....
Federal watchdogs are once again setting their sights on perceived improper billing practices by home health agencies. In an audit report published...
A company developing allogeneic cell therapies for blood cancers, autoimmune diseases and genetic diseases has raised nearly $200 million in its latest...